Literature DB >> 11786457

Evidence based case report. Antibiotic treatment for spontaneous bacterial peritonitis.

K Soares-Weiser1, M Paul, M Brezis, L Leibovici.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11786457      PMCID： PMC1121993          DOI： 10.1136/bmj.324.7329.100

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  19 in total

Review 1.  Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.

Authors:  A Rimola; G García-Tsao; M Navasa; L J Piddock; R Planas; B Bernard; J M Inadomi
Journal:  J Hepatol       Date:  2000-01       Impact factor: 25.083

Review 2.  Spontaneous bacterial peritonitis.

Authors:  C Guarner; G Soriano
Journal:  Semin Liver Dis       Date:  1997       Impact factor: 6.115

Review 3.  Antibiotics for spontaneous bacterial peritonitis in cirrhotics.

Authors:  K Soares-Weiser; M Brezis; L Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2001

4.  Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study.

Authors:  R Terg; S Cobas; E Fassio; G Landeira; B Ríos; W Vasen; R Abecasis; H Ríos; M Guevara
Journal:  J Hepatol       Date:  2000-10       Impact factor: 25.083

5.  Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis.

Authors:  M Deschênes; J P Villeneuve
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

6.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Authors:  P Sort; M Navasa; V Arroyo; X Aldeguer; R Planas; L Ruiz-del-Arbol; L Castells; V Vargas; G Soriano; M Guevara; P Ginès; J Rodés
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

7.  Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.

Authors:  E Ricart; G Soriano; M T Novella; J Ortiz; M Sàbat; L Kolle; J Sola-Vera; J Miñana; J M Dedéu; C Gómez; J L Barrio; C Guarner
Journal:  J Hepatol       Date:  2000-04       Impact factor: 25.083

8.  Evaluation of the therapeutic effect of pefloxacin in comparison with ampicillin and gentamicin in cirrhotic patients with spontaneous bacterial peritonitis.

Authors:  L A Rastegar; G Umrani; N Dehbashi; F Malec
Journal:  Hepatogastroenterology       Date:  1998 May-Jun

9.  Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.

Authors:  M Navasa; A Follo; J M Llovet; G Clemente; V Vargas; A Rimola; F Marco; C Guarner; M Forné; R Planas; R Bañares; L Castells; M T Jimenez De Anta; V Arroyo; J Rodés
Journal:  Gastroenterology       Date:  1996-10       Impact factor: 22.682

10.  A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients.

Authors:  P A McCormick; L Greenslade; C C Kibbler; J K Chin; A K Burroughs; N McIntyre
Journal:  Hepatology       Date:  1997-04       Impact factor: 17.425
View more
  2 in total

1.  Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation.

Authors:  Alexander B Benson; James R Burton; Gregory L Austin; Scott W Biggins; Michael A Zimmerman; Igal Kam; Susan Mandell; Christopher C Silliman; Hugo Rosen; Marc Moss
Journal:  Liver Transpl       Date:  2011-02       Impact factor: 5.799

2.  Spontaneous bacterial peritonitis: a severe complication of liver cirrhosis.

Authors:  Jan Lata; Oldrich Stiburek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.